Zota Health Care [ZOTA] vs Titan Bio-Tech [TITANBIO] Detailed Stock Comparison

Zota Health Care Limited

NSE
Loading...

Titan Bio-Tech Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zota Health Care Limited wins in 5 metrics, Titan Bio-Tech Ltd. wins in 13 metrics, with 0 ties. Titan Bio-Tech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zota Health Care Limited Titan Bio-Tech Ltd. Better
P/E Ratio (TTM) -62.53 74.64 Titan Bio-Tech Ltd.
Price-to-Book Ratio 12.61 12.19 Titan Bio-Tech Ltd.
Debt-to-Equity Ratio 56.90 5.32 Titan Bio-Tech Ltd.
PEG Ratio -0.59 -1.22 Zota Health Care Limited
EV/EBITDA -126.59 61.34 Titan Bio-Tech Ltd.
Profit Margin (TTM) -15.37% 14.13% Titan Bio-Tech Ltd.
Operating Margin (TTM) -15.88% 16.92% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) N/A 16.92% N/A
Return on Equity -24.83% 14.04% Titan Bio-Tech Ltd.
Return on Assets (TTM) -12.84% 12.32% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $-959.42M $106.79M Titan Bio-Tech Ltd.
Dividend Yield 0.07% 0.42% Titan Bio-Tech Ltd.
1-Year Return 27.17% 419.45% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 8.34 10.54 Zota Health Care Limited
Enterprise Value $45.66B $20.35B Zota Health Care Limited
EV/Revenue Ratio 9.66 10.57 Zota Health Care Limited
Gross Profit Margin (TTM) 60.28% N/A N/A
Revenue per Share (TTM) $157 $47 Zota Health Care Limited
Earnings per Share (Diluted) $-23.94 $6.58 Titan Bio-Tech Ltd.
Beta (Stock Volatility) 0.36 -0.48 Titan Bio-Tech Ltd.

Zota Health Care Limited vs Titan Bio-Tech Ltd. Stock Performance Analysis

Loading Price Chart...

ZOTA
TITANBIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zota Health Care Limited1.75%3.68%3.22%14.06%-26.10%-17.99%
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zota Health Care Limited27.17%243.00%632.12%1,248.00%1,248.00%1,248.00%
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%

Performance & Financial Health Analysis: Zota Health Care Limited vs Titan Bio-Tech Ltd.

MetricZOTATITANBIO
Market Information
Market Cap i₹39.41B₹19.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i56,41168,890
90 Day Avg. Volume i53,265156,601
Last Close₹1,246.70₹448.30
52 Week Range₹917.20 - ₹1,740.00₹74.73 - ₹555.65
% from 52W High-28.35%-19.32%
All-Time High₹1,740.00 (Nov 21, 2025)₹1,460.00 (Feb 18, 2026)
% from All-Time High-28.35%-69.29%
Growth Metrics
Quarterly Revenue Growth0.98%0.48%
Quarterly Earnings Growth1.12%0.94%
Financial Health
Profit Margin (TTM) i-0.15%0.14%
Operating Margin (TTM) i-0.16%0.17%
Return on Equity (TTM) i-0.25%0.14%
Debt to Equity (MRQ) i56.905.32
Cash & Liquidity
Book Value per Share (MRQ)₹103.04₹40.29
Cash per Share (MRQ)₹1.87₹0.87
Operating Cash Flow (TTM) i₹-1,007,999,000₹197.75M
Levered Free Cash Flow (TTM) i₹-563,984,000₹215.32M
Dividends
Last 12-Month Dividend Yield i0.07%0.42%
Last 12-Month Dividend i₹1.00₹4.00

Valuation & Enterprise Metrics Analysis: Zota Health Care Limited vs Titan Bio-Tech Ltd.

MetricZOTA (Apr 22, 2026)TITANBIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-62.5374.64
Forward P/E iN/AN/A
PEG Ratio i-0.59-1.22
Price to Sales (TTM) i8.3410.54
Price to Book (MRQ) i12.6112.19
Market Capitalization
Market Capitalization i₹39.41B₹19.90B
Enterprise Value i₹45.66B₹20.35B
Enterprise Value Metrics
Enterprise to Revenue i9.6610.57
Enterprise to EBITDA i-126.5961.34
Risk & Other Metrics
Beta i0.36-0.48
Book Value per Share (MRQ) i₹103.04₹40.29

Financial Statements Comparison: Zota Health Care Limited vs Titan Bio-Tech Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZOTA (2025)TITANBIO (2025)
Revenue/Sales i2.93B1.56B
Cost of Goods Sold i1.44B892.53M
COGS % of Revenue i49.0%57.0%
Gross Profit i1.49B671.98M
Gross Margin i51.0%43.0%
Research & Development iN/AN/A
Operating Income (EBIT) i-480.90M212.57M
Operating Margin i-16.4%13.6%
EBITDA i-42.20M285.61M
EBITDA Margin i-1.4%18.3%
Pre-Tax Income i-576.44M243.67M
Pre-Tax Income % of Revenue i-19.7%15.6%
Income Tax i-9.06M60.96M
Income Tax % of Revenue i-0.3%3.9%
Net Income (Profit) i-567.39M215.32M
Profit Margin i-19.4%13.8%

Balance Sheet & Liquidity Metrics

MetricZOTA (2025)TITANBIO (2025)
Cash & Equivalents i21.32M51.28M
Total Current Assets i1.84B790.38M
Total Current Assets % of Revenue i62.9%50.5%
Total Current Liabilities i1.01B177.36M
Total Current Liabilities % of Revenue i34.3%11.3%
Long-Term Debt i1.08B4.19M
Long-Term Debt % of Revenue i36.7%0.3%
Total Shareholders Equity i2.27B1.53B
Retained Earnings i-191.89M1.36B
Retained Earnings % of Revenue i-6.5%87.0%
Property, Plant & Equipment i65.25M571.62M

Cash Flow Statement Comparison

MetricZOTA (2025)TITANBIO (2025)
Operating Cash Flow i-1.01B197.75M
Operating Cash Flow % of Revenue i-34.4%12.6%
Capital Expenditures i-459.67M-85.26M
Free Cash Flow i-959.42M106.79M
FCF Margin i-32.7%6.8%
Debt Repayment i-140.67M-2.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZOTATITANBIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i30.33M41.32M
Float Shares i15.02M13.13M
% Held by Insiders i0.00%68.21%
% Held by Institutions i1.16%0.00%
% Held by Public i98.84%31.79%

Dividend Analysis & Yield Comparison: Zota Health Care Limited vs Titan Bio-Tech Ltd.

MetricZOTATITANBIO
Last 12-Month Dividend i₹1.00₹4.00
Last 12-Month Dividend Yield i0.07%0.42%
3-Year Avg Annual Dividend i₹1.00₹1.93
3-Year Avg Dividend Yield i0.16%0.34%
3-Year Total Dividends i₹3.00₹5.80
Ex-Dividend DateSep 22, 2025Sep 19, 2025